NCT03052101View on ClinicalTrials.gov

Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Pulmonary Langerhans Cell Histiocytosis
Trial Locations (1)

45267-0564

University of Cincinnati, Cincinnati

All Listed Sponsors
collaborator

Rare Diseases Clinical Research Network

NETWORK

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Cincinnati

OTHER

NCT03052101 - Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis | Biotech Hunter | Biotech Hunter